Lacto-N-fucopentaose I
Selected Variant
HY-W019806-01
Size: 1 mg
Lacto-N-fucopentaose I (LNFPI) is a human milk oligosaccharide (HMO), possessing antiviral and antibacterial activity. Lacto-N-fucopentaose I can reduce capsid protein VP1 to block virus adsorption, promote CDK2 and reduce cyclin E to recover cell cycle S phase block. Lacto-N-fucopentaose I inhibits ROS production and apoptosis in virus-infected cells. Lacto-N-fucopentaose I can also regulate intestinal microbiota to affect immune system development[1].
Product Specifications
CAS Number
7578-25-8
Product Name Alternative
LNFP I
UNSPSC
12352005
Target
Apoptosis; Bacterial; CDK; Endogenous Metabolite; Enterovirus; Reactive Oxygen Species (ROS)
Type
Natural Products
Related Pathways
Anti-infection; Apoptosis; Cell Cycle/DNA Damage; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
COVID-19-anti-virus
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/lacto-n-fucopentaose-i.html
Purity
99.92
Solubility
H2O : 125 mg/mL (ultrasonic)
Smiles
Molecular Formula
C32H55NO25
Molecular Weight
853.77
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
CDK2; Human Endogenous Metabolite
Available Sizes
Price
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD11b / MAC-1 (Microglial Marker) (ITGAM/3337), 0.2mg/mL
Human IgG Immunoglobulin (B33/20), CF488A conjugate, 0.1mg/mL
Vinculin (Marker of Age-related Macular Degeneration) (VCL/2575), CF488A conjugate, 0.1mg/mL
